NZ710322A - A novel formulation of metaxalone - Google Patents
A novel formulation of metaxaloneInfo
- Publication number
- NZ710322A NZ710322A NZ710322A NZ71032210A NZ710322A NZ 710322 A NZ710322 A NZ 710322A NZ 710322 A NZ710322 A NZ 710322A NZ 71032210 A NZ71032210 A NZ 71032210A NZ 710322 A NZ710322 A NZ 710322A
- Authority
- NZ
- New Zealand
- Prior art keywords
- metaxalone
- compositions
- methods
- medicaments
- dissolution
- Prior art date
Links
Abstract
The present disclosure relates to methods for producing particles of metaxalone using dry milling processes to produce particles of the biologically active material dispersed in an at least partially milled grinding matrix as well as compositions comprising metaxalone, medicaments produced using metaxalone in particulate form and/or compositions, and to methods of treatment of an animal, including man, using a therapeutically effective amount of metaxalone administered by way of said medicaments. wherein the milled metaxalone has a dissolution profile, when tested using USP Apparatus II (paddles) set to rotation speed of 100 RPM in 1000 mL of 0.01 M HCl at pH 2 at 37±0.5°C, of no less than 15% dissolution, by weight, at 60 minutes, when measured under sink conditions.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17228109P | 2009-04-24 | 2009-04-24 | |
| AU2009901743A AU2009901743A0 (en) | 2009-04-24 | A Novel Formulation of Metaxalone | |
| NZ62088610 | 2010-04-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ710322A true NZ710322A (en) | 2017-04-28 |
Family
ID=58700210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ710322A NZ710322A (en) | 2009-04-24 | 2010-04-23 | A novel formulation of metaxalone |
Country Status (1)
| Country | Link |
|---|---|
| NZ (1) | NZ710322A (en) |
-
2010
- 2010-04-23 NZ NZ710322A patent/NZ710322A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ710384A (en) | A novel formulation of indomethacin | |
| NZ595987A (en) | A novel formulation of diclofenac | |
| NZ595903A (en) | A novel formulation of metaxalone | |
| PH12015501780A1 (en) | Production of encapsulated nanoparticles at commercial scale | |
| NZ595902A (en) | Method for the production of commercial nanoparticle and microparticle powders | |
| PH12016500746A1 (en) | A novel formulation of meloxicam | |
| NZ599069A (en) | Methods for the Preparation of Biologically Active Compounds in Nanoparticulate Form | |
| NZ595973A (en) | Production of encapsulated nanoparticles at high volume fractions | |
| TN2011000536A1 (en) | A novel formulation of naproxen | |
| NZ710322A (en) | A novel formulation of metaxalone | |
| AU2014208310B2 (en) | A Novel Formulation of Diclofenac | |
| TH135130A (en) | Methods for improving the solubility profile of bioactive materials. | |
| NZ710321A (en) | Production of encapsulated nanoparticles at high volume fractions | |
| TH125552B (en) | Production of nanoparticles trapped at high volumetric ratios | |
| PH12015501811A1 (en) | Production of encapsulated nanoparticles at high volume fractions | |
| TH125552A (en) | Production of nanoparticles trapped at high volumetric ratios | |
| TH140026A (en) | The new recipe of indomethacin. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 6 YEARS UNTIL 23 APR 2020 BY WRAYS Effective date: 20171120 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 APR 2021 BY WRAYS PTY LTD Effective date: 20200409 |
|
| LAPS | Patent lapsed |